[Skip to Navigation]
Sign In
April 4, 2012

Recommendations on Use of Prostate-Specific Antigen for Prostate Cancer Screening

Author Affiliations

Author Affiliation: Department of Medicine, Beth Israel Deaconess Medical Center, Boston Massachusetts (mgarnick@bidmc.harvard.edu).

JAMA. 2012;307(13):1372-1374. doi:10.1001/jama.2012.396

To the Editor: Three Commentaries1-3 provided differing interpretations of the conclusion from the draft report of the US Preventive Services Task Force (USPSTF) that the harms of prostate-specific antigen (PSA) screening outweigh the benefits of treatment for PSA screen-detected prostate cancer and of the recommendation against the routine use of the test. Scientific evidence is lacking for their arguments for continuing the widespread use of PSA testing.

Add or change institution